GoBroad Healthcare Group

What GoBroad Healthcare Group does

GoBroad Healthcare Group (高博医疗集团), legally Beijing GoBroad Medical Technology Group Co., Ltd., is a privately held Chinese research hospital network founded in 2017. It operates eight hospitals across Beijing, Shanghai, and Guangzhou/Dongguan with approximately 1,500 beds, more than 100 Class 100 laminar airflow transplant rooms, two reference laboratories, and one central laboratory. The group specializes in hematologic malignancies, complex solid tumors, and autoimmune diseases, with particular depth in hematopoietic stem cell transplantation (HSCT), CAR-T cell therapy, and gene therapy, and reports a cumulative track record of 4,000+ HSCT procedures and 5,000+ CAR-T therapies. Clinical care is delivered through a patient-driven Multidisciplinary Care (MDC) model and anchored by senior clinicians recruited from leading Chinese institutions such as Fudan University-affiliated centers and Shanghai General Hospital.

The business model combines three revenue streams: (1) direct hospital medical services for domestic patients (covered by Shanghai medical insurance, national cross-regional settlement, and commercial health insurance), (2) international patient services through a dedicated International Patient Service Center offering pre-arrival, in-hospital, and post-discharge coordination, and (3) clinical research services for pharmaceutical companies conducting innovative therapy trials. The group publishes in high-impact hematology and oncology journals (Blood, Leukemia) and presents at ASH and EHA congresses, positioning itself as a clinical research platform rather than a general hospital chain. International expansion began with a November 2025 strategic MOU with Indonesia's Sentra Medika Hospital Group for oncology and hematology collaboration, supported by a multilingual website (Chinese, English, Russian, Arabic) and a WhatsApp/email-staffed international coordinator function. No revenue, funding, or ownership figures are disclosed in the available source material.

Name

GoBroad Healthcare Group

Legal name

Beijing GoBroad Medical Technology Group Co., Ltd.

Website

https://gobroadhealthcare.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

GoBroad Healthcare Group is a privately held Chinese research hospital network operating eight hospitals in Beijing, Shanghai, and Guangzhou with ~1,500 beds, specializing in hematologic malignancies, solid tumors, and autoimmune diseases through CAR-T therapy, HSCT, and gene therapy.

Ownership category

akta.pro rank

Product category

Specialty Hospital Services (Hematology and Oncology)

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Pediatric Hematology & Oncology (HLAKAFAE)

Keywords

• Specialty hospital services
• Hematology oncology care
• CAR-T cell therapy
• Hematopoietic stem cell transplantation
• Clinical research services

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Hospital Medical Services: Revenue generated from patient medical services including diagnostics, treatments, surgeries, hospitalizations, and follow-up care across its network of 8 hospitals in Beijing, Shanghai, and Guangzhou.
2. International Patient Services: Revenue from international patients utilizing the dedicated International Patient Service Center for consultation, treatment coordination, and healthcare services.
3. Clinical Research Services: Research hospital model providing clinical research services, serving hundreds of innovative pharmaceutical companies with trial capabilities across multiple therapeutic areas.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

GoBroad Healthcare Group operates a network of 8 specialized research hospitals in Beijing, Shanghai, and Guangzhou providing advanced diagnosis and treatment of hematologic malignancies, solid tumors, and autoimmune diseases. Core clinical offerings include CAR-T cell therapy, hematopoietic stem cell transplantation (HSCT), gene therapy, and multidisciplinary cancer care, supported by a dedicated International Patient Service Center.

Product overview

GoBroad Healthcare Group is a leading research-oriented medical organization in China comprising a network of specialized hospitals and treatment centers. The group operates 8 hospitals in Beijing, Shanghai, and Guangzhou with nearly 1,500 available beds. Its core portfolio includes Beijing GoBroad Hospital (research hospital for solid tumors, hematologic tumors, and brain science), Beijing GoBroad Boren Hospital, Shanghai GoBroad Cancer Hospital (tertiary-grade oncology research hospital), GoBroad Shanghai Zhaxin Hospital/Shanghai Liquan Hospital (hematology institute), and GoBroad Chunfu Institute of Hematology & Oncology (pediatric hematology and oncology). The group specializes in advanced cell-based therapies including CAR-T cell therapy, hematopoietic stem cell transplantation (HSCT/BMT), and gene therapy, delivered through a Multidisciplinary Care (MDC) model. An International Patient Service Center provides coordination for global patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Beijing GoBroad Hospital Flagship research hospital in Beijing operated by GoBroad Healthcare Group, providing advanced diagnosis and treatment of hematologic malignancies, solid tumors, and autoimmune diseases for adult and pediatric patients.
• Beijing GoBroad Boren Hospital

Quantifiable outcome

• 97.84% overall survival rate for thalassemia patients through innovative transplantation strategies
• +5 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Rumah Sakit Sentra Medika Cibinong (Sentra Medika Hospital Group)significantStrategic or Co-development Partner · 1 November 2025GoBroad Healthcare Group and Sentra Medika Hospital Group of Indonesia signed a Strategic Memorandum of Understanding (MOU) in November 2025. The partnership marks a significant step in bilateral cooperation in oncology and hematology care, clinical research, and talent development. Sentra Medika Hospital Group, with over 41 years of development, operates multiple general hospitals across Indonesia with KARS Paritty accreditation. The collaboration includes high-level medical exchange, capacity building in oncology and hematology, joint clinical research, enhancement of innovative therapy accessibility, and development of standardized training programs. GoBroad brings expertise with over 4,000 HSCT procedures, 5,000 CAR-T therapies, and nearly 70 international publications.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Apollo Hospitals Enterprise: Large hospital network in India that has expanded into oncology-focused specialty care and medical tourism. Comparable as a multi-specialty incumbent that has built cancer centers competing for international patients.
• Fortis Healthcare: Multi-specialty hospital group in India and Asia with significant oncology and hematology offerings. Comparable to GoBroad as a broader incumbent that has developed specialty oncology capabilities and serves international patients.
• IHH Healthcare: Asia-Pacific hospital network operator with significant oncology and hematology exposure across Malaysia, Singapore, Turkey, and India. Comparable to GoBroad as broad incumbent serving international patients with cell therapy and BMT capabilities.

Direct peers

• Memorial Sloan Kettering Cancer Center: Specialty cancer hospital network with leading hematology and cell therapy programs. Comparable to GoBroad as a research-driven oncology hospital system focused on complex and refractory cases.
• MD Anderson Cancer Center: Global leader in oncology specialty hospital care and research, with deep expertise in CAR-T, HSCT, and complex cancer cases. Highly comparable to GoBroad's cancer and hematology specialty hospital network serving high-acuity patients.
• ICON Group: Australia-headquartered oncology and hematology hospital network operating across multiple geographies. Closest international comparable to GoBroad's specialty oncology hospital model with cross-border partnerships.

Regional players

• Bumrungrad International Hospital: Leading medical tourism hospital in Southeast Asia (Thailand) serving international patients across multiple specialties including oncology. Comparable to GoBroad's international patient center and outbound medical tourism strategy.
• Bangkok Dusit Medical Services (BDMS): Largest private hospital network in Thailand with strong oncology and medical tourism focus. Comparable to GoBroad as a regional Southeast Asian hospital group competing for international patient flow.

Emerging players

• CARsgen Therapeutics: Chinese CAR-T developer pursuing both hematologic and solid tumor indications. Comparable to GoBroad as a China-based cell therapy organization operating at the intersection of biotech and clinical delivery.
• China Medical System Holdings: Hong Kong-listed Chinese healthcare group with hospital and specialty care exposure. Comparable to GoBroad as an emerging Chinese private healthcare player building specialty medical offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/GoBroadGHG
• YouTubeyoutube.com/channel/UCTs04tS75YTxmfHfKwnamGQ
• Facebookfacebook.com/profile.php
• Instagraminstagram.com/gobroadhealthcare?igsh=MWV5ZmkwcXZhbGpiYg%3D%3D&utm_source=qr
• LinkedInlinkedin.com/company/%E9%AB%98%E5%8D%9A%E5%8C%BB%E7%96%97%E9%9B%86%E5%9B%A2

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GoBroad Healthcare Group